8-Aminocyclazocine analogues: Synthesis and structure-activity relationships

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 2, 2000, Pages 183-187

  Wentland, Mark P ^a   Xu, Guoyou ^a   Cioffi, Christopher L ^a   Ye, Yingchun ^a   Duan, Wenhu ^a   Cohen, Dana J ^b   Colasurdo, Ann M ^b   Bidlack, Jean M ^b  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; CYCLAZOCINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; PALLADIUM;

AMINATION; ARTICLE; BINDING AFFINITY; CATALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0034677132     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00670-8     Document Type: Article

References (24)

1. Archer S., Glick S.D., Bidlack J.M. Neurochem. Res. 21:1996;1369.
2. Fink, M.; Freedman, A. M.; Resnick, R.; Zaks, A. In Agonist and Antagonist Actions of Narcotic Analgesic Drugs; Kosterlitz, H. W.; Collier, H. O. J.; Villareal, J. G., Eds.; Macmillan, 1971; pp 266-276.
3. Wentland M.P., Albertson N.F., Pierson A.K. J. Med. Chem. 23:1980;71.
4. Todd S.L., Balster R.L., Martin B.R. Life Sci. 46:1990;895.
5. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Pharmacol. Rev. 42:1990;355.
6. For all optically active compounds reported in this paper, the (-)-isomers are (2R,6R,11R) and the (+)-isomers are (2S,6S,11S).
7. De Costa B.R., Dowen W.D., Hellewell S.B., Walker J.M., Thurkauf A., Jacobson A.E., Rice K.C. FEB Letters. 251:1989;53.
8. Brine G.A., Berrang B., Hayes J.P., Carroll F.I. J. Het. Chem. 27:1990;2139.
9. Tullar B.F., Harris L.S., Perry R.L., Pierson A.K., Soria A.E., Wetterau W.F., Albertson N.F. J. Med. Chem. 10:1967;383.
10. Danso-Danquah R., Bai X., Zhang X., Mascarella S.W., Williams W., Sine B., Bowen W.D., Carroll F.I. J. Med. Chem. 38:1995;2978.
11. Proton NMR, IR, MS were consistent with the assigned structures of all new compounds. C, H, and N elemental analyses were obtained for all new targets and most intermediates and were within ±0.4% of theoretical values.
12. Hartwig J.F. Angew. Chem., Int. Ed. 37:1998;2046.
13. Buchwald S.L., Wolfe J.P. J. Org. Chem. 62:1997;1264.
14. Louie J., Driver M.S., Hamann B.C., Hartwig J.F. J. Org. Chem. 62:1997;1268.
15. 2O: C, 81.77; H, 8.58; N, 7.95. Found: C, 81.60; H, 8.64; N, 7.78. This reaction was performed on a larger scale (3-fold) giving a similar yield of (±)-10 (mp, 144-146 °C).
16. 3-Tris(dibenzylideneacetone)dipalladium(0); DPPF-1,1′-bis(diphenyl-phosphino)-ferrocene.
17. Wolfe J.P., Åhman J., Sadighi J.P., Singer R.A., Buchwald S.L. Tetrahedron Lett. 38:1997;6367.
18. Mascarella S.W., Bai X., Williams W., Sine B., Bowen W.D., Carroll F.I. J. Med. Chem. 38:1995;565.
19. Fürst S., Hosztafi S., Friedmann T. Curr. Med. Chem. 1:1995;423.
20. Aldrich, J. V. In Burger's Medicinal Chemistry and Drug Discovery; Wolff, M. E., Ed.; John Wiley & Sons: New York, 1996; Vol. 3, pp 321-441.
21. Archer S., Seyed-Mozaffari A., Jiang Q., Bidlack J.M. J. Med. Chem. 37:1994;1578.
22. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.
23. Newman A.H., Bevan K., Bowery N., Tortella F.C. J. Med. Chem. 35:1992;4135.
24. Tortella F.C., Britton P., Williams A., Lu X.C.M., Newman A.H. J. Pharm. Exp. Ther. 291:1999;399.